Mangoceuticals (MGRX) Revenue (2023 - 2026)

Mangoceuticals has disclosed Revenue across 4 years of filings, most recently posting $67864.0 for Q1 2026.

• Revenue for Q1 2026 came in at $67864.0, down 37.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $414579.0 (down 18.88% YoY), and the FY2025 annual result was $456021.0, down 25.96% from the prior year.
• Revenue came in at $67864.0 for Q1 2026 at Mangoceuticals, down from $94360.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $245160.0 in Q3 2023 to a low of $67864.0 in Q1 2026.
• The 4-year median for Revenue is $133368.0 (2024), against an average of $143942.4.
• Peak annual rise in Revenue reached 112.56% in 2024, while the deepest fall reached 56.93% in 2024.
• Mangoceuticals' Revenue stood at $244374.0 in 2023, then slumped by 56.93% to $105247.0 in 2024, then slipped by 10.34% to $94360.0 in 2025, then declined by 28.08% to $67864.0 in 2026.
• The last three Revenue figures came in at $67864.0 (Q1 2026), $94360.0 (Q4 2025), and $84246.0 (Q3 2025), per Business Quant data.